|drug2140||Next generation Sequencing (NGS) analysis Wiki||1.00|
|drug2749||Rapid molecular test Wiki||1.00|
|drug4007||serological test Wiki||1.00|
There is one clinical trial.
Translational, prospective / retrospective, non-profit, non-pharmacological study, with cohort characteristics. The study consists of two parts: the first to study epidemiological aspects of the spread of the disease and the second one to identify infection-related genetic factors.
Description: Investigate the epidemiology of the infection in an asymptomatic population including both healthy individuals at high risk of infection and oncological patients by assessing the seroprevalence of IgG and IgM antibodies against the SARS-CoV-2Measure: epidemiology Time: 12 months
Description: IgG and IgM antibodies evaluation over timeMeasure: Immunoglobulin G (IgG) and Immunoglobulin M (IgM) antibodies evaluation Time: 12 months
Description: Make a comparison between different serological investigation methods and rapid molecular methods becoming availableMeasure: methods comparison Time: 24 months
Description: To evaluate correlation between biochemical and coagulative factors with SARS-CoV-2 positivityMeasure: correlation between biochemical and coagulative factors with SARS-CoV-2 positivity. Time: 24 months
Description: Building a phylogenetic map of an epidemic Italian macro-regionMeasure: phylogenetic map Time: 24 months
Description: Evaluate the spectrum of possible interactions between the virus and host cells, considering their genetic variability / instability in patients diagnosed with COVID-19Measure: interactions between the virus and host cells Time: 24 months
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports